Natalee Cramer was one of 20,000 fans who cheered on the Dallas Mavericks basketball team during a game. At halftime, the ...

Here are The Enquirer's all-city teams for boys and girls soccer in Divisions I through V in Ohio, plus Northern Kentucky and ...

Beginning Jan. 6, Detroit People Mover General Manager Robert Cramer will begin his role as executive director of transit with a $225,000 salary. Former interim DDOT director Michael Staley ...

CNBC's Jim Cramer explained why the markets fell after the Federal Reserve announced an interest rate cut and said there will likely be fewer cuts than expected next year. Weak industries like ...

Police say the infant died in October of 2022 in Nanticoke while under the care of her mother, Natalee Rasmus. An autopsy revealed the infant's cause of death was asphyxia due to mechanical ...

We recently compiled a list of the Jim Cramer's Bold Predictions About These 15 Tech Stocks. In this article, we are going to take a look at where Cadence Design Systems, Inc. (NASDAQ:CDNS ...

Nvidia pre-market stock price. Source: Google Finance This downturn has caught the attention of former hedge fund manager and Mad Money host, Jim Cramer, who recently issued a cautionary note. “Still ...

We recently compiled a list of the Jim Cramer’s Bold Predictions About These 15 Tech Stocks. In this article, we are going to take a look at where Palantir Technologies Inc. (NYSE:PLTR ...

We recently compiled a list of the Jim Cramer's Bold Predictions About These 15 Tech Stocks. In this article, we are going to take a look at where Amazon.com, Inc. (NASDAQ:AMZN) stands against the ...

"I think it’s a very good situation," Cramer on Cooper Companies. Jim Cramer says Occidental Petroleum is one of his "least favorite oils." On Monday, UBS analyst Josh Silverstein maintained ...

In this article, we will take a detailed look at Jim Cramer’s December Portfolio: Top 10 Stocks to Watch. Jim Cramer in a latest program on CNBC talked about the evolution of AI and how the ...

EAST HANOVER, N.J., Dec. 10, 2024 /PRNewswire/ -- Novartis today announced results from an updated analysis of the pivotal Phase III NATALEE trial of Kisqali ® (ribociclib) that underscore the ...